undefined undefined
NaN.000
NaN.00%
ReShape Lifesciences (NASDAQ:RSLS) on Thursday filed a prospectus related to the proposed resale of 11.7M common shares by the selling stockholders. This prospectus is not an offer to sell these secur...
05-10 00:22
ReShape Lifesciences press release (NASDAQ:RSLS): FY net loss of $11.4M. Revenue of $8.68M (-22.8% Y/Y) misses by $0.22M. Shares +2.21%. More on ReShape Lifesciences ReShape Lifesciences gets notice o...
04-02 04:44
Reshape Lifesciences (NASDAQ:RSLS) reported quarterly sales of $8.678 million which missed the analyst consensus estimate of $8.904 million by 2.54 percent.
04-02 04:08
ReShape Lifesciences (NASDAQ:RSLS) Thursday announced that the company has received a notice of allowance from the U.S. Patent and Trademark Office for a patent entitled, “Intragastric Device.” When i...
03-28 20:56
ReShape Lifesciences Reaffirms Commitment To Profitability
03-04 09:46
ReShape Lifesciences Expects 2024 Operating Expenses Down 55.4% YoY
03-04 09:45
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48.
2023-12-14 03:30
U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose, gaining, 0.20% to 4,653.07.
2023-12-14 01:05
ReShape Lifesciences, Inc. (NASDAQ: RSLS) shares are trading higher Wednesday after the company announced it has received FDA PMA supplement approval for
2023-12-14 01:04